Blockade of the human cardiac K+ channel Kv1.5 by the antibiotic erythromycin

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 355, Issue 6, 1997, Pages 743-750

  Rampe, David ^a   Murawsky, Michael K ^a  

^a Hoechst Marion Roussel ^*  (United States)

Author keywords

Arrhythmias; Erythromycin; Human; Kv1.5; Potassium channels

Indexed keywords

ERYTHROMYCIN; POTASSIUM CHANNEL;

ARTICLE; DRUG EFFECT; EMBRYO CELL; HEART ARRHYTHMIA; HEART REPOLARIZATION; HUMAN; HUMAN CELL; KINETICS; PATCH CLAMP;

CELL LINE; ELECTRIC STIMULATION; EMBRYO; ERYTHROMYCIN; HEART; HUMANS; KIDNEY; MEMBRANE POTENTIALS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS;

EID: 0030853695     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005008     Document Type: Article

References (32)

1. Amos GJ, Wettwer E, Metzger F, Li Q, Himmel HM, Ravens U (1996) Differences between outward currents of human atrial and subepicardial ventricular myocytes. J Physiol (Lond) 491: 31-50
2. Armstrong CM, Bezanilla F (1977) Inactivation of the sodium channel. II. Gating current experiments. J Gen Physiol 70: 567-590
3. Austin KL, Mather LE, Philpot CR, McDonald PJ (1980) Inter-subject and dose-related variability after intravenous administration of erythromycin. Br J Clin Pharmacol 10: 273-279
4. ks cardiac potassium current. Nature 384: 78-80
5. + channels? Circ Res 77: 361-369
6. Brandriss MW, Richardson WS, Barold SS (1994) Erythromycin-shy; induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): Case report and review. Clin Infec Dis 18: 995-998
7. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT (1995) A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80: 795-803
8. Daleau P, Lessard E, Groleau M-F, Turgeon J (1995) Erythromycin blocks the rapid component of the delayed rectifier potassium current and lengthens repolarization of guinea pig ventricular myocytes. Circulation 91: 3010-3016
9. Davies AJ, Harindra V, McEwan A, Ghose RR (1989) Cardiotoxic effect with convulsions in terfenadine overdose. Br Med J 298: 325
10. Dette GA, Knothe H, Kellner H-M (1987) Whole body tissue distribution of [14C]-erythromycin in the guinea pig. An autoradiographic study. Arzneimittelforschung 37: 524-527
11. + channel current. Circ Res 73: 210-216
12. Freedman RA, Anderson KP, Green LS, Mason JW (1987) Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. Am J Cardiol 59: 168-169
13. Gordon RC, Regamey C, Kirby WMM (1973) Serum protein binding of erythromycin, lincomycin and clindumycin. J Pharm Sci 62: 1074-1077
14. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch clamp techniques for high resolution current recording from cells and cell-tree membrane patches. Pfluegers-Arch. 391: 85-100
15. Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR (1992) Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 52: 231-238
16. Hoshi T, Zagotta WN, Aldrich RW (1994) Shaker potassium channel gating. I: Transitions near the open state. J Gen Physiol 103: 249-278
17. + current in human ventricular myocytes. Circ Res 78: 689-696
18. Malayev AA, Nelson DJ, Philipson LH (1995) Mechanism of clofilium block of the human Kv1.5 delayed rectifier potassium channel. Mol Pharmacol 47: 198-205
19. + channel protein in explanted cardiac tissue. J Clin Invest 96: 282-292
20. McComb JM, Campbell NPS, Cleland J (1984) Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin. Am J Cardiol 54: 922-923
21. Monahan BP, Ferguson CL, Killeavy ES, Lloyd BK, Troy J, Cantilena LR (1990) Torsades de pointes occurring in association with terfenadine use. JAMA 264: 2788-2790
22. Peck CC, Temple R, Collins JM (1993) Understanding consequences of concurrent therapies. JAMA 269: 1550-1552
23. Ponsonnaille J, Citron B, Richard A, Trolese JF, Chaperon A, Barret B, Gras H (1988) Etude electrophysiologique des effets pro-arythmogenes de l'erythromycine. Arch Mal Coeur 81: 1001-1008
24. Ragosta M, Weihl AC, Rosenfeld LE (1989) Potentially fatal interaction between erythromycin and disopyramide. Am J Med 86: 465-466
25. + channel cloned from human heart. Mol Pharmacol 44: 1240-1245
26. Roberds SL, Knoth KM, Po S, Blair A, Bennett PB, Hartshorne RP, Snyders DJ, Tamkun MM (1993) Molecular biology of the voltage-gated potassium channels of the cardiovascular system. J Cardiovasc Electrophysiol 4: 68-80
27. 1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ Res 76: 110-119
28. Kr potassium channel. Cell 81: 299-307
29. Ks potassium channel. Nature 384: 80-83
30. Thompson D, Oster G (1996) Use of terfenadine and contraindicated drugs. JAMA 275: 1339-1341
31. Wang Z, Fermini B, Nattel S (1993) Sustained depolarization-induced outward current in human atrial myocytes: Evidence for a novel delayed rectifier potassium current similar to Kv1.5 cloned channel currents. Circ Res 73: 1061-1076
32. Woosley RL, Chen Y, Freiman JP, Gillis RA (1993) Mechanism of the cardiotoxic actions of terfenadine. JAMA 268: 1532-1536